Soliton, which is developing a medical device for tattoo removal, filed on Friday with the SEC for a best-efforts initial public offering under Regulation A+.
The Houston, TX-based company plans to raise a minimum of $7.5 million and a maximum of $15.0 million by offering between 1.5 million and 3.0 million shares at a price of $5. With the max offering at the proposed price, Soliton would command a fully diluted market value of $83 million.
Soliton was founded in 2012 and plans to list on the Nasdaq under the symbol SOLY. Boustead Securities is the sole underwriter on the deal. IPO timing was not disclosed.
As a min-max, best-efforts offering under Reg A+, we are not tracking this deal in our IPO stats.
